Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Harpole

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Thoracic Surgery Clinics|July 14, 2007
Prognostic modeling in early stage lung cancer: an evolving process from histopathology to genomicsDavid H Harpole
Surgical Oncology Clinics of North America|November 22, 2011
Molecular markers for incidence, prognosis, and response to therapyBetty C Tong, David H Harpole
Cancer Investigation|February 10, 2006
The surgical management of lung cancerKatherine E Posther, David H Harpole
Thoracic Surgery Clinics|December 13, 2007
Audit, quality control, and performance in thoracic surgery: a North American perspectiveBetty C Tong, David H Harpole
Thoracic Surgery Clinics|January 24, 2007
Lung cancer staging: proteomicsDavid H Harpole, Shari L Meyerson
Journal of the National Comprehensive Cancer Network : JNCCN|July 4, 2006
Computed tomography screening for the early detection of lung cancerRebecca P Petersen, David H Harpole
Chest Surgery Clinics of North America|December 10, 2002
Intraoperative techniques to prevent air leaksEric M Toloza, David H Harpole
Seminars in Thoracic and Cardiovascular Surgery|October 29, 2005
Surgical strategies and outcomes after induction therapy for non-small cell lung cancerWilliam R Burfeind, David H Harpole
Thoracic Surgery Clinics|November 28, 2015
The Biology of Pulmonary MetastasisChristopher D Scott, David H Harpole
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survivalMichael S Kinch, Mary-Beth Moore, David H Harpole
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Thoracic Surgery Clinics|July 14, 2007
Prognostic modeling in early stage lung cancer: an evolving process from histopathology to genomicsDavid H Harpole
Surgical Oncology Clinics of North America|November 22, 2011
Molecular markers for incidence, prognosis, and response to therapyBetty C Tong, David H Harpole
Cancer Investigation|February 10, 2006
The surgical management of lung cancerKatherine E Posther, David H Harpole
Thoracic Surgery Clinics|December 13, 2007
Audit, quality control, and performance in thoracic surgery: a North American perspectiveBetty C Tong, David H Harpole
Thoracic Surgery Clinics|January 24, 2007
Lung cancer staging: proteomicsDavid H Harpole, Shari L Meyerson
Journal of the National Comprehensive Cancer Network : JNCCN|July 4, 2006
Computed tomography screening for the early detection of lung cancerRebecca P Petersen, David H Harpole
Chest Surgery Clinics of North America|December 10, 2002
Intraoperative techniques to prevent air leaksEric M Toloza, David H Harpole
Seminars in Thoracic and Cardiovascular Surgery|October 29, 2005
Surgical strategies and outcomes after induction therapy for non-small cell lung cancerWilliam R Burfeind, David H Harpole
Thoracic Surgery Clinics|November 28, 2015
The Biology of Pulmonary MetastasisChristopher D Scott, David H Harpole
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survivalMichael S Kinch, Mary-Beth Moore, David H Harpole
Pageof 13